LEQEMBI IQLIK®(lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer's Disease
Go back to LEQEMBI IQLIK®(lecanemab-irmb) Autoinjector for Initiation of Therapy Now Available in the U.S. for Early Alzheimer's Disease| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 217.57 +0.42 (0.19%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $217.15 | 52 Week High | $333.65 | |||
| Open | $221.00 | 52 Week Low | $223.02 | |||
| Day High | $222.25 | P/E | 27.86 | |||
| Day Low | $215.56 | EPS | $7.81 | |||
| Volume | 237,487 | |||||
